Ryder(R)
Search documents
Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay
Accessnewswire· 2025-09-23 10:30
Core Viewpoint - Zomedica Corp. has expanded its TRUFORMA diagnostic platform to include feline testing capabilities for its cobalamin and folate assay, marking a significant advancement in veterinary diagnostics [1] Group 1: Product Development - The TRUFORMA diagnostic platform now offers a multiplexed assay that combines cobalamin and folate testing, which was previously available only for canine patients [1] - This assay is the first of its kind to provide both cobalamin and folate testing in an in-clinic setting, enhancing the diagnostic capabilities for veterinarians [1] Group 2: Market Position - Zomedica is positioned as an innovative veterinary health company focused on point-of-care diagnostic and therapeutic device products for both equine and companion animals [1]
3 Stocks From the Transport Equipment & Leasing Industry to Watch
ZACKS· 2025-09-22 17:45
Core Viewpoint - The Zacks Transportation - Equipment and Leasing industry is facing a challenging macroeconomic environment characterized by persistent inflation, tariff-related tensions, and supply-chain disruptions, alongside geopolitical issues [1][5]. Industry Overview - The industry encompasses companies that provide equipment financing, leasing, and supply-chain management services, including aircraft, railcar, and intermodal container lessors. It also includes logistics and transportation solutions for a diverse customer base, primarily in automotive, electronics, transportation, grocery, lumber, food service, and home furnishing sectors [3]. Financial Performance and Shareholder Returns - Companies like Wabtec Corporation and Ryder System are noted for their shareholder-friendly initiatives, such as dividend payouts and share buybacks, indicating strong financial health. Ryder recently approved a 12% dividend increase, raising its quarterly cash dividend to 91 cents per share, while Wabtec announced a 25% increase, raising its quarterly cash dividend from 20 cents to 25 cents [2][4]. Economic Challenges - The industry is grappling with ongoing tariff tensions and inflation, which contribute to economic uncertainty and may hinder stock performance. Supply-chain disruptions and rising operating costs are also limiting growth potential [5][6]. Industry Ranking and Performance - The Zacks Transportation - Equipment and Leasing industry holds a Zacks Industry Rank of 75, placing it in the top 31% of over 250 Zacks industries. However, it has underperformed compared to the S&P 500 and the broader sector over the past year, declining 18.4% against the S&P 500's increase of 18.7% [7][9][10]. Current Valuation - The industry is currently trading at a forward 12-month price-to-earnings (P/E) ratio of 13.99X, which is lower than the S&P 500's 23.52X and the sector's 13.84X. Historically, the industry has traded between 8.42X and 15.65X over the past five years [13]. Notable Companies to Watch - **Wabtec Corporation**: Focused on technology-based locomotives and services, Wabtec has shown strong earnings performance, with a 17.6% expected earnings growth rate for 2025 [17][19]. - **Ryder System**: A logistics and transportation company with a long history of dividend payments, Ryder has an expected earnings growth rate of 9.3% for 2025 [22][23]. - **The Greenbrier Companies**: Specializing in railroad freight car equipment, Greenbrier has a notable earnings surprise history and an expected earnings growth rate of 33.1% for 2025 [26][28].
iFabric Announces Renewal of License Agreement with TUMI to Continue Integration of PROTX2(R) Technology
Accessnewswire· 2025-09-22 14:05
MARKHAM, ON / ACCESS Newswire / September 22, 2025 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF) today announced that its wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has renewed its license agreement with TUMI, Inc. ("TUMI") to continue integrating IFTNA's PROTX2® antimicrobial solutions across select TUMI products. The renewal extends the relationship first announced on May 5, 2021, by a further period of five years. ...
Inverite Achieves Milestone SOC 2(R) Type II Audit Validation and Data Security Controls
Newsfile· 2025-09-18 12:00
Inverite Achieves Milestone SOC 2(R) Type II Audit Validation and Data Security ControlsSeptember 18, 2025 8:00 AM EDT | Source: Inverite Insights Inc.Vancouver, British Columbia--(Newsfile Corp. - September 18, 2025) - Inverite Insights Inc. (CSE: INVR) (OTC Pink: INVRD) (FSE: 2V0) ("Inverite") is a leading AI-driven software provider utilizing real-time financial data to empower businesses to transact more effectively with consumers, today announced it has successfully completed its SOC 2® T ...
Zomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. Patents
Accessnewswire· 2025-09-18 10:30
Core Insights - Zomedica Corp. has strengthened its intellectual property portfolio with the issuance of four additional U.S. patents for its TRUVIEW and TRUFORMA diagnostic platforms [1] - The veterinary diagnostics market is currently valued between $8 billion and $11 billion and is projected to grow to $17 billion to $22 billion by 2030-2032, with a compound annual growth rate (CAGR) of 9-11% [1] Company Summary - Zomedica now holds a total of 228 patents and 153 trademarks, providing robust protection for its product platforms [1] - The company focuses on innovative point-of-care diagnostic and therapeutic device products for equine and companion animals [1]
enVVeno Medical Updates Regulatory Status of VenoValve(R)
Accessnewswire· 2025-09-15 12:45
Core Viewpoint - enVVeno Medical Corporation is seeking to appeal the not-approvable letter from the FDA regarding its VenoValve® device for treating severe deep chronic venous insufficiency [1] Group 1: Company Actions - The company plans to file a request for a supervisory appeal to challenge the FDA's decision received on August 19, 2025 [1] - The appeal will utilize the FDA's internal mechanisms to contest the review staff's decision, which may involve scientific controversies [1] Group 2: Product Information - The VenoValve® is a surgical replacement venous valve designed for the treatment of severe deep chronic venous insufficiency (CVI) [1]
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW(R) Digital Cytology Microscope - Transforming Veterinary Imaging
Accessnewswire· 2025-09-12 10:30
Core Insights - Zomedica Corp. is showcasing its TRUVIEW digital cytology microscope in a webinar series aimed at innovation in veterinary care [1] - The TRUVIEW microscope enhances digital cytology and hematology practices by enabling rapid and high-quality image capture and interpretation [1] Company Overview - Zomedica is a veterinary health company focused on advanced diagnostic and therapeutic solutions for companion and equine animals [1] Industry Impact - The introduction of the TRUVIEW microscope represents a significant advancement in veterinary diagnostic technology, potentially improving the efficiency and accuracy of veterinary practices [1]
Horizon Kinetics Holding Corporation (HKHC) Upgrades to Trade on OTCQX(R) Best Market
Accessnewswire· 2025-09-08 16:02
Core Insights - Horizon Kinetics Holding Corporation upgraded to OTCQX from OTCID™ Basic Market, enhancing its market visibility and trading status [1] Company Summary - Horizon Kinetics Holding Corporation is the holding company for Horizon Kinetics Asset Management LLC [1] - The company began trading on OTCQX under the symbol "HKHC" on September 5th, 2025 [1]
Burcon Achieves First Commercial Production of Puratein(R)C Canola Protein
Newsfile· 2025-09-04 12:00
Company Overview - Burcon NutraScience Corporation is a global technology leader in plant-based protein innovation, focusing on high-performance plant-based proteins for the food and beverage industry [5] - The company has a strong patent portfolio covering novel proteins derived from various plant sources, including pea, canola, soy, hemp, and sunflower [5] Recent Developments - Burcon has successfully commenced commercial production of Puratein®C, a high-purity canola protein isolate with over 90% protein content, available for immediate delivery [1][3] - The production milestone is a significant step in Burcon's strategy to scale revenue and expand its portfolio of next-generation plant proteins [1][2] Product Details - Puratein C is extracted from non-GMO, North American-grown canola seeds and features a complete amino acid profile, including all nine essential amino acids [3] - The product has a Protein Digestibility-Corrected Amino Acid Score (PDCAAS) of 1, indicating its high nutritional value [3] - Puratein C is suitable for a wide range of applications, including dairy alternatives, ready-to-drink beverages, meat analogues, sauces, and baked goods [3] Market Opportunity - The global demand for high-quality, sustainable protein is accelerating, positioning Burcon's proprietary canola protein technology as a compelling solution [2] - The successful production of three proteins at commercial scale demonstrates Burcon's technology platform and execution capability, creating multiple new revenue streams [2]
3 Dividend-Paying Transport Equipment & Leasing Stocks to Watch
ZACKS· 2025-08-29 19:36
Industry Overview - The Zacks Transportation - Equipment and Leasing industry is facing a challenging macroeconomic environment characterized by persistent inflation, tariff-related tensions, and supply-chain disruptions, along with geopolitical issues [1] - The industry has underperformed compared to the Zacks S&P 500 Composite and the broader Zacks Transportation sector, gaining only 1.8% over the past three months, while the S&P 500 increased by 10.1% and the broader sector rose by 3.3% [2] Company Highlights - Companies like The Greenbrier Companies, Ryder Corporation, and Air Lease Corporation are noted for their solid investor-friendly initiatives, including consistent dividend payouts and share buybacks, indicating strong financial health [3][7] - Dividend growth stocks are typically mature companies that provide downside protection against market volatility, supported by strong fundamentals such as sustainable business models, profitability, rising cash flows, good liquidity, and strong balance sheets [4] Stock Selection Criteria - A dividend payout ratio of less than 60% is considered sustainable, indicating a healthy balance between earnings and dividends [8] - A dividend yield greater than 1% is preferred, with selected stocks showing dividend growth over the past five years and carrying a Zacks Rank of 3 (Hold) or better [9] Company Specifics Greenbrier Companies (GBX) - Headquartered in Lake Oswego, OR, Greenbrier has a market capitalization of $1.50 billion and pays a quarterly dividend of $0.32, yielding 2.72% [10] - The company's payout ratio is 18%, with a five-year dividend growth rate of 3.47% [10] - In 2022, Greenbrier paid $35.8 million in dividends and repurchased no shares; in 2023, it paid $36.1 million in dividends and repurchased $56.9 million; in 2024, dividends were $38.4 million with $1.3 million in share repurchases [12] Ryder Corporation (R) - Based in Coral Gables, FL, Ryder has a market capitalization of $7.64 billion and pays a quarterly dividend of $0.91, yielding 1.94% [13] - The payout ratio is 26%, with a five-year dividend growth rate of 9.47% [13] - Ryder returned $123 million in dividends and $557 million in share repurchases in 2022; in 2023, it paid $128 million in dividends and repurchased $337 million; in 2024, it returned $456 million to shareholders [14] Air Lease Corporation (AL) - Headquartered in Los Angeles, CA, Air Lease has a market capitalization of $6.76 billion and pays a quarterly dividend of $0.22, yielding 1.45% [15][16] - The payout ratio is 17%, with a five-year dividend growth rate of 8.34% [16]